Search here for articles and publications that mention the business activities of Fujifilm Diosynth Biotechnologies or feature our scientists and executive leadership in interviews or profiles.
Bio-Ess Laboratories and FUJIFILM Diosynth Biotechnologies Find That Cell-Ess Media Supplement Improves Viral Production for VaccineOctober 3, 2017
Bio-Ess Laboratories and FUJIFILM Diosynth Biotechnologies have collaborated on a study which has shown that Cell-Ess Universal Titer Boost allows for the replacement of serum in influenza virus production in MDCK cells.Read More
Dr. Andy Topping, chief scientific officer at FUJIFILM Diosynth Biotechnologies, talks about the science behind the work to be performed in the newly open Saturn Process Development Laboratories.
Arecor, the Centre for Process Innovation (CPI), and FUJIFILM Diosynth Biotechnologies (FDB) today announced that its collaboration project entitled ‘Improving Downstream Operation through Formulation Innovation’ has successfully completed its initial rounds of downstream performance testing of formulations, which have shown very positive resultsRead More
Winner of the Global Biotechnology Award at the prestigious IChemE (Institute of Chemical Engineers) Award ceremony held in Manchester, England.Read More
Department taps Centers for Innovation in Advanced Development and ManufacturingRead More
Arecor, CPI and FUJIFILM Diosynth Biotechnologies collaborate to apply smart formulation approaches in the manufacturing of biopharmaceuticals under a grant awarded by Innovate UK.Read More
In the Fall 2015 edition of Innovation Tech & Today, we are featured in an interview with Martin Meeson "FUJIFILM's Amazing Biotechnology".Read More
Read an article from our Head of Process Design, Dr. Graham McCreath, in preparation of his presentation on Process Characterization at #BPIconf in October 2015.Read More
In the Summer 2015 edition of Innovation & Tech Today, we are featured in an interview with John Foy "Driving the Process of Biotech".Read More
Optimize No Cell Line before Its Time. Delicate Balancing of the Cell-Line Terroir Will Not Overcome Fundamental Quality IssuesRead More
After launching a new mammalian cell platform, FUJIFILM Diosynth Biotechnologies U.S.A., has acquired fast-track vaccine manufacturing knowhow and a major presence in Texas’ emerging biocorridor with Kalon, its first acquisition.Read More
Dr. Simon Dewar, Head of Upstream R&D Operations, FUJIFILM Diosynth Biotechnologies and Dr. Fern Slingsby, Lead Scientist, Upstream Development, FUJIFILM Diosynth BiotechnologiesRead More